双边乳腺癌 双边乳腺癌
1Division of Breast and Endocrine Surgery, Department of Surgery, Nihon University School of Medicine.
The American surgeon
|February 21, 2025
概括
双边乳腺癌 (BBC),包括同步性乳腺癌 (SBBC) 和超时性乳腺癌 (MBBC),具有不同的风险因素和预后. 了解这些差异对于改善患者的治疗结果和治疗策略至关重要.
科学领域:
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
- 流行病学 流行病学
背景情况:
- 双边乳腺癌 (BBC) 包括同步 (SBBC) 和超时 (MBBC) 诊断.
- 这些疾病占所有乳腺癌病例的很大一部分.
- 风险因素和预后在SBBC和MBBC之间有所不同.
研究的目的:
- 审查和澄清SBBC和MBBC的不同特征.
- 识别和比较与每种类型的BBC相关的风险因素.
- 阐明SBBC和MBBC相对于单侧乳腺癌 (UBC) 的预后影响.
主要方法:
- 对双边乳腺癌现有研究的文献综述.
- 对有关发病率的流行病学数据的分析.
- 基于患者年龄,组织学和遗传因素的风险因素和生存结果的比较.
主要成果:
- SBBC的危险因素包括年龄和叶片组织学.
- 结核血的危险因素包括年龄较小,球状组织学和遗传因素.
- 对于SBBC的预后通常比UBC更糟;MBBC的预后仍然不清楚.
结论:
- SBBC和MBBC表现出不同的风险因素概况.
- 需要进一步的研究来澄清MBBC预后和患者特定因素的影响.
- 区分SBBC和MBBC对于促进双边乳腺癌的理解和管理至关重要.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K


